Patents by Inventor Gyoo-yeol Jung
Gyoo-yeol Jung has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11535854Abstract: The present invention relates to a novel microorganism capable of metabolizing various carbon sources at high rates. A novel microorganism according to the present invention was observed to grow at a very high rate in a minimal medium/nutrient medium, etc., compared to microorganisms such as Escherichia coli, and shows resistance at a high initial sugar/salt concentrations as well as being able to produce lycopene and 2,3-butanediol through genetic manipulation. Therefore, the novel microorganism can be used in various production fields of high value-added compounds using microorganisms.Type: GrantFiled: May 11, 2018Date of Patent: December 27, 2022Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION, SEOUL NATIONAL UNIVERSITY R & DB FOUNDATIONInventors: Gyoo Yeol Jung, Dong Hun Kwak, Sang Woo Seo, Hyun Gyu Lim
-
Publication number: 20220213540Abstract: The present invention relates to a novel probe set for an isothermal one-pot reaction, and uses thereof and, particularly, provides a method for easily, accurately, and quickly diagnosing molecules, in particular, infection diseases, in the field, the method having a form applicable in the field on the basis of a nucleic acid sequence by using a one-pot reaction composition under an isothermal condition. If a molecular diagnostic platform according to the present invention is used, a target sequence can be quickly and accurately detected.Type: ApplicationFiled: April 22, 2020Publication date: July 7, 2022Inventors: Jeong Wook LEE, Gyoo Yeol JUNG, Chang Ha WOO, Sungho Jang, Giyoung SHIN
-
Patent number: 11013221Abstract: The present invention relates to: a transgenic Caenorhabditis elegans in which a glutamine tRNA 5? terminus-derived fragment (Gln 5?-tsRNA) is overexpressed; a preparation method therefor; and a method for screening for aging-associated factors by using the transgenic Caenorhabditis elegans. A transgenic Caenorhabditis elegans model provided in the present invention is an animal model in which Gln 5?-tsRNA is overexpressed such that aging is inhibited. When the model of the present invention is used, anti-aging mechanisms can be easily investigated, thereby significantly contributing to various research fields such as that of developing new anti-aging drugs and screening for age-inducing materials.Type: GrantFiled: April 21, 2017Date of Patent: May 25, 2021Assignees: POSTECH ACADEMY-INDUSTRY FOUNDATION, INSTITUTE FOR BASIC SCIENCE, DAEGU GYEONGBUK INSTITUTE OF SCIENCEInventors: Hong Gil Nam, Gyoo Yeol Jung, Seung Jae Lee, Woo Seon Hwang, Gi Won Shin, Mi Hwa Seo
-
Publication number: 20200354755Abstract: The present invention relates to a novel microorganism capable of metabolizing various carbon sources at high rates. A novel microorganism according to the present invention was observed to grow at a very high rate in a minimal medium/nutrient medium, etc., compared to microorganisms such as Escherichia coli, and shows resistance at a high initial sugar/salt concentrations as well as being able to produce lycopene and 2,3-butanediol through genetic manipulation. Therefore, the novel microorganism can be used in various production fields of high value-added compounds using microorganisms.Type: ApplicationFiled: May 11, 2018Publication date: November 12, 2020Inventors: Gyoo Yeol Jung, Dong Hun Kwak, Sang Woo Seo, Hyun Gyu Lim
-
Publication number: 20190200589Abstract: The present invention relates to: a transgenic Caenorhabditis elegans in which a glutamine tRNA 5? terminus-derived fragment (Gln 5?-tsRNA) is overexpressed; a preparation method therefor; and a method for screening for aging-associated factors by using the transgenic Caenorhabditis elegans. A transgenic Caenorhabditis elegans model provided in the present invention is an animal model in which Gln 5?-tsRNA is overexpressed such that aging is inhibited. When the model of the present invention is used, anti-aging mechanisms can be easily investigated, thereby significantly contributing to various research fields such as that of developing new anti-aging drugs and screening for age-inducing materials.Type: ApplicationFiled: April 21, 2017Publication date: July 4, 2019Applicants: Postech Academy-Industry Foundation, Institute for Basic Science, Daegu Gyeongbuk Institute of ScienceInventors: Hong Gil NAM, Gyoo Yeol JUNG, Seung Jae LEE, Woo Seon HWANG, Gi Won SHIN, Mi Hwa SEO
-
Patent number: 9919932Abstract: The present invention relates to a method for preparing a nickel ferrite nanoparticle composite having an inverse spinel structure obtained using a polyol process, a nickel ferrite nanoparticle composite prepared by the method, and a method for selectively binding, separating or purifying a specific protein using the nickel ferrite nanoparticle composite. The method for preparing a magnetic nanoparticle composite according to the present invention includes a one-step hydrothermal synthesis process, and thereby the magnetic nanoparticle composite can be prepared in a simple and economic manner. Also, the nickel ferrite nanoparticles synthesized by the method of the present invention can be strongly magnetic, and also exist in the form of Ni2+ in which Ni binds to a specific protein, thereby preventing loss of separability caused by additional oxidation and repeated recycling of the nanoparticles.Type: GrantFiled: March 29, 2012Date of Patent: March 20, 2018Assignee: POSTECH ACADEMY-INDUSTRY FOUNDATIONInventors: Gyoo Yeol Jung, Sang Woo Seo, Jinyoung Chun, Jinwoo Lee
-
Patent number: 9493767Abstract: A method of screening a high L-tryptophan-producing microorganism using a riboswitch is provided. More particularly, a riboswitch for screening a high L-tryptophan-producing microorganism including a tryptophan aptamer, a DNA sequence consisting of 1 to 20 nucleotides and a selectable marker gene, and a method of screening a high L-tryptophan-producing microorganism using the same are provided. The riboswitch and the method of screening a high L-tryptophan-producing microorganism using the same can be useful in selecting a strain producing a high concentration of L-tryptophan in a relatively quick and easy manner, and thus enhancing price competitiveness of tryptophan production using microorganisms.Type: GrantFiled: June 19, 2013Date of Patent: November 15, 2016Assignee: POSTECH ACADEMY-INDUSTRY FOUNDATIONInventors: Gyoo Yeol Jung, Jina Yang, SungHo Jang, Sang Woo Seo
-
Publication number: 20150337293Abstract: A method of screening a high L-tryptophan-producing microorganism using a riboswitch is provided. More particularly, a riboswitch for screening a high L-tryptophan-producing microorganism including a tryptophan aptamer, a DNA sequence consisting of 1 to 20 nucleotides and a selectable marker gene, and a method of screening a high L-tryptophan-producing microorganism using the same are provided. The riboswitch and the method of screening a high L-tryptophan-producing microorganism using the same can be useful in selecting a strain producing a high concentration of L-tryptophan in a relatively quick and easy manner, and thus enhancing price competitiveness of tryptophan production using microorganisms.Type: ApplicationFiled: June 19, 2013Publication date: November 26, 2015Applicant: POSTECH ACADEMY-INDUSTRY FOUNDATIONInventors: Gyoo Yeol Jung, Jina Yang, SungHo Jang, Sang Woo Seo
-
Publication number: 20140163209Abstract: The present invention relates to a method for preparing a nickel ferrite nanoparticle composite having an inverse spinel structure obtained using a polyol process, a nickel ferrite nanoparticle composite prepared by the method, and a method for selectively binding, separating or purifying a specific protein using the nickel ferrite nanoparticle composite. The method for preparing a magnetic nanoparticle composite according to the present invention includes a one-step hydrothermal synthesis process, and thereby the magnetic nanoparticle composite can be prepared in a simple and economic manner. Also, the nickel ferrite nanoparticles synthesized by the method of the present invention can be strongly magnetic, and also exist in the form of Ni2+ in which Ni binds to a specific protein, thereby preventing loss of separability caused by additional oxidation and repeated recycling of the nanoparticles.Type: ApplicationFiled: March 29, 2012Publication date: June 12, 2014Applicant: Postech Academy-Industry FoundationInventors: Gyoo Yeol Jung, Sang Woo Seo, Jinyoung Chun, Jinwoo Lee
-
Publication number: 20120181175Abstract: The present invention relates to filler for analyzing capillary electrophoresis-based single strand conformation polymorphism, and to a method for using the filler for analyzing capillary electrophoresis-based single strand conformation polymorphism, and more particularly, to filler for analyzing capillary electrophoresis-based single strand conformation polymorphism, the filler containing a polymer micelle formed by dispersing a sandwich-block copolymer comprising (Hydrophilic group)-(Hydrophobic group)-(Hydrophilic group) in an aqueous medium, and to a method for using the filler for analyzing capillary electrophoresis-based single strand conformation polymorphism.Type: ApplicationFiled: October 9, 2009Publication date: July 19, 2012Applicant: THE BIO CO., LTDInventors: Hyun Kee Kim, Gyoo Yeol Jung, Gi Won Shin, Hee Sung Hwang
-
Patent number: 5593856Abstract: A method for producing protein in a cell-free system uses cell-free extract required for protein production, extracted from a biological cell. According to the present invention, a wide range of proteins can be produced economically and efficiently even in a semi-continuous operation mode, by regenerating energy source, increasing operation time of the reactor with porous solid material and using selective protein isolating means having high specific affinity to a desired protein. Thus, problems appearing in the living cell (in vivo) system due to the absence of post-translational processing can be avoided and the total production amount can be greatly increased due to prolonged operation time of the reactor and increased protein productivity.Type: GrantFiled: August 25, 1994Date of Patent: January 14, 1997Assignee: Cha-yong ChoiInventors: Cha-yong Choi, Dong-myung Kim, Gyoo-yeol Jung